2023-08-31Influenza vaccinations (NTNU)
Influenza vaccinations for employees at NTNU autumn 2023, with an option for equivalent vaccinations in 2024 and/or 2025. Procurement of influenza vaccination.
Vis anskaffelsen » Nevnte leverandører:Hjemmelegene AS
2022-11-25Enhanced quadrivalent influenza vaccine against seasonal influenza for the 2023/2024 influenza season (Folkehelseinstituttet)
The Norwegian Institute of Public Health (FHI) is inviting tenderers to an open tender for an Enhanced quadrivalent influenza vaccine against seasonal influenza for vaccination of particularly vulnerable persons from 65 years and older (nursing home residents, users of home nursing care, etc.) An enhanced quadrivalent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
The aim is to enter …
Vis anskaffelsen » Nevnte leverandører:Seqirus UK Limited
2022-09-19Four valent vaccination against seasonal influenza (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] is holding an open tender contest with the aim of ensuring sufficient delivery of four valent vaccine against seasonal influenza (ATC code J07B B02) for vaccination of persons in defined risk and target groups (see the tender documentation point 1.4) for the 2023/2024 and 2024/2025 seasons, with an option for a further two seasons.
The contest is being held electronically in the CTM KGV and information given in the tender management tool, …
Vis anskaffelsen » Nevnte leverandører:Sanofi-aventis Norge ASViatris AS
2022-04-19National vaccine preparedness against pandemic influenza (Folkehelseinstituttet)
The Norwegian Institute of Public Health is carrying out an open tender contest for the procurement of vaccine preparedness against pandemic influenza on behalf of the Ministry of Health and Care Services. The objective of the procurement is to ensure that Norway's residents have access to a vaccine in the event of an influenza pandemic occurring in the contract period.
The procurement shall be carried out as an open tender contest in accordance with the Public Procurement Act Parts 1 and 3. The …
Vis anskaffelsen » Nevnte leverandører:Seqirus UK Limited
2021-12-21Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season (Folkehelseinstituttet)
The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) …
Vis anskaffelsen » Nevnte leverandører:Seqirus
2021-04-22Enhanced 4-valent Vaccine Against Seasonal Influenza (Folkehelseinstituttet)
The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme. The procurement is carried out on behalf of the Ministry of Health and Care Services (HOD).
The procurement will follow the rules for an …
Vis anskaffelsen »
2016-03-14Seasonal influenza vaccine (Nasjonalt Folkehelseinstitutt (FHI) (The Norwegian Institute of Public Health))
The objective of the procurement is to ensure sufficient supply of vaccine against seasonal influenza (ATC code J07B B02). The vaccine shall be given to defined risk groups for the seasons 2016-2017 and 2017/2018, with option for 2 additional seasons. Due to security of supply, the Contracting Authority will enter into contracts with 3 suppliers, cf. OAF § 15-3.
Vis anskaffelsen »
2013-07-04Pandemic influenza vaccine (Nasjonalt folkehelseinstitutt)
The Norwegian Institute of Public Health (NIPH), on behalf of the Norwegian Ministry of Health and Care Services, will conduct a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of this tender is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period. The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period. The …
Vis anskaffelsen » Nevnte leverandører:GlaxoSmithKline ASNovartis Norge AS
2011-08-31Vaccine against seasonal influenza (Nasjonalt folkehelseinstitutt)
The Norwegian Institute of Public Health, henceforth referred to as the Awarding Authority, shall carry out an open tender contest for purchase of vaccine against seasonal influenza for the seasons 2012/2013 and 2013/2014 with option for the 2 coming seasons.
NOTE: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at http://www.doffin.no/Search/Search_Switch.aspx?ID=238420.
Vis anskaffelsen »